Personal Capital Advisors Corp increased its position in shares of Xylem Inc (NYSE:XYL) by 48.1% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 9,289 shares of the industrial products company’s stock after buying an additional 3,018 shares during the period. Personal Capital Advisors Corp’s holdings in Xylem were worth $742,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Flagship Harbor Advisors LLC purchased a new position in Xylem during the second quarter valued at $106,000. Smithfield Trust Co. lifted its holdings in Xylem by 1,690.0% during the second quarter. Smithfield Trust Co. now owns 1,611 shares of the industrial products company’s stock valued at $108,000 after purchasing an additional 1,521 shares in the last quarter. Fort L.P. acquired a new stake in shares of Xylem in the second quarter valued at about $118,000. Stelac Advisory Services LLC acquired a new stake in shares of Xylem in the second quarter valued at about $125,000. Finally, Piedmont Investment Advisors LLC acquired a new stake in shares of Xylem in the second quarter valued at about $139,000. 85.85% of the stock is currently owned by institutional investors and hedge funds.

In related news, Director Curtis J. Crawford sold 1,323 shares of the firm’s stock in a transaction dated Friday, August 3rd. The shares were sold at an average price of $75.25, for a total transaction of $99,555.75. Following the completion of the sale, the director now directly owns 40,421 shares in the company, valued at $3,041,680.25. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Kairus Tarapore sold 18,800 shares of the firm’s stock in a transaction dated Friday, August 3rd. The stock was sold at an average price of $75.17, for a total transaction of $1,413,196.00. Following the sale, the senior vice president now owns 31,580 shares of the company’s stock, valued at $2,373,868.60. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 49,284 shares of company stock valued at $3,839,982. 0.81% of the stock is owned by company insiders.

A number of brokerages have recently commented on XYL. Berenberg Bank began coverage on shares of Xylem in a research report on Wednesday, October 3rd. They issued a “sell” rating and a $65.00 target price for the company. Vertical Research cut shares of Xylem from a “hold” rating to a “sell” rating in a research report on Monday, October 8th. Stifel Nicolaus increased their target price on shares of Xylem from $75.00 to $80.00 and gave the company a “hold” rating in a research report on Wednesday, August 1st. Raymond James began coverage on shares of Xylem in a research report on Wednesday, September 5th. They issued an “outperform” rating and a $90.00 target price for the company. Finally, BMO Capital Markets increased their target price on shares of Xylem from $83.00 to $84.00 and gave the company an “outperform” rating in a research report on Wednesday, August 1st. Two analysts have rated the stock with a sell rating, four have assigned a hold rating and nine have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $81.75.

Shares of NYSE XYL opened at $69.77 on Friday. The stock has a market capitalization of $14.35 billion, a PE ratio of 29.07, a price-to-earnings-growth ratio of 1.52 and a beta of 1.22. The company has a quick ratio of 1.02, a current ratio of 1.43 and a debt-to-equity ratio of 0.86. Xylem Inc has a 52 week low of $62.24 and a 52 week high of $82.44.

Xylem (NYSE:XYL) last released its quarterly earnings data on Tuesday, July 31st. The industrial products company reported $0.73 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.71 by $0.02. Xylem had a net margin of 7.39% and a return on equity of 19.04%. The firm had revenue of $1.32 billion during the quarter, compared to analysts’ expectations of $1.28 billion. During the same period last year, the business earned $0.59 earnings per share. Xylem’s revenue was up 13.1% compared to the same quarter last year. As a group, equities research analysts predict that Xylem Inc will post 2.91 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 7th. Investors of record on Thursday, November 1st will be given a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a yield of 1.20%. The ex-dividend date of this dividend is Wednesday, October 31st. Xylem’s payout ratio is currently 35.00%.

Xylem Company Profile

Xylem Inc engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Measurement and Control Solutions. The Water Infrastructure segment offers various products, including water and wastewater pumps, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, Godwin, Wedeco, Sanitaire, and Leopold names for the transportation, treatment, and testing of water and wastewater applications.

Read More: Analyzing a company’s cash flow statement

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc (NYSE:XYL).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.